Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA Revokes Orphan Drug Designation For Indivior’s Sublocade
Nov 12 2019
•
By
Sue Sutter
US FDA has revoked Sublocade's orphan drug designation 25 years after it was granted. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Legal & IP
More from Pink Sheet